Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06632301 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DEXA Bone Density Analysis of the CoreHip® Prosthesis System

Study acronym: CODEX
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Sep 2027 → Sep 2028
See other at-risk trials from Aesculap AG

Record History

  1. Primary completion pushed from Sep 2027 to Sep 2028 Start date: Jun 2026 to Dec 2026v6 Show 1 more changeShow less
    • Start date: Jun 2026 to Dec 2026
  2. Primary completion date: Dec 2026 to Sep 2027 Start date: Dec 2025 to Jun 2026 · Completion date: May 2027 to Sep 2028v5 Show 2 more changesShow less
    • Start date: Dec 2025 to Jun 2026
    • Completion date: May 2027 to Sep 2028
  3. Primary completion date: Dec 2025 to Dec 2026 Start date: Jun 2025 to Dec 2025 · Completion date: May 2026 to May 2027v4 Show 2 more changesShow less
    • Start date: Jun 2025 to Dec 2025
    • Completion date: May 2026 to May 2027
  4. Primary completion date: May 2025 to Dec 2025 Start date: Dec 2024 to Jun 2025v3 Show 1 more changeShow less
    • Start date: Dec 2024 to Jun 2025
  5. Start date: Nov 2024 to Dec 2024v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aesculap AG
32 trials monitored
See 6 trials at risk
The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.
Trial Details
NCT Number NCT06632301
Lead Sponsor Aesculap AG
Conditions Primary Osteoarthritis, Cartilage Degeneration, Osteoarthritis, Hip, Inflammatory Arthritis, Osteonecrosis of Femoral Head, Traumatic Disorder
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov